Navigation Links
CDC Recommends Flocked Swabs and Copan-Manufactured Viral Transport Media for Collection of H1N1 (Swine Flu) Virus
Date:5/5/2009

MURRIETA, Calif., May 5 /PRNewswire/ -- As of May 5, 2009, the World Health Organization, has officially reported 1124 cases of Influenza A (H1N1) infection in 21 different countries. As the situation with the novel H1N1 (Swine Flu) virus continues to evolve, the Centers for Disease Control and Prevention (CDC) continue to update their document Interim Guidance on Specimen Collection and Processing for Patients with Suspected Influenza A (H1N1) Virus. The objective of this document is to provide guidance on appropriate specimen collection, storage, processing, and testing for patients with suspected swine-origin influenza A (H1N1) virus infection.

One of the most widely used methods for detection of H1N1 flu virus is to collect a nasopharyngeal swab sample. The CDC recommends the use of synthetic tip swabs, such as Flocked Swabs, which exhibit a superior recovery of viruses. Several independent scientific studies published in the Journal of Clinical Microbiology and presented at Clinical Virology Symposium show that the quality of the sample taken using Copan Flocked Swabs is comparable to the quality of a sample collected from a nasopharyngeal aspirate or nasal was, which are considered the gold standard for upper respiratory virus samples. The open structure of Copan Flocked Swabs acts like a soft brush that efficiently dislodges and collects cells and mucus, then releases the sample immediately when put in a viral transport medium. In Ontario, the Agency for Health Protection and Promotion also lists Flocked Swabs as the preferred type of swab for respiratory virus sample collection on its latest version of LABstract on H1N1 Flu Virus (human swine influenza), Updated Guidance for Laboratory Testing, Hospital Setting. Copan Flocked Swabs are easy to use, are less invasive and cause minimal discomfort for the patient. Copan holds a worldwide patent on Flocked Swabs.

To transport H1N1 viral specimens collected using swabs, the CDC also recommends that the swab specimen collection vials should contain 1 - 3ml of viral transport medium (e.g. containing, protein stabilizer, antibiotics to discourage bacterial and fungal growth, and buffer solution), such as the BD Universal Viral Transport System, which is manufactured by Copan and distributed in different parts of the world under the Copan brand name Universal Transport Medium (UTM). Copan UTM is room temperature stable and available in vials containing 1 or 3 ml of transport medium for different applications.

About Copan Diagnostics, Inc.

With a reputation for innovation in preanalytics, Copan is the leading manufacturer of collection and transport systems in the world. Copan offers a complete range of microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit www.copanusa.com


'/>"/>
SOURCE Copan Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
2. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
3. American College of Physicians recommends flu vaccination for health-care workers
4. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
5. FDA Panel Recommends Ban on Cold Medicines for Kids
6. AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies
7. National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning
8. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
9. Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius Opposition Slate
10. FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
11. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: